NCT03267017 is a clinical trial of posture changes in Heart Rate Determination, sponsored by Rambam Health Care Campus.

Who is sponsoring NCT03267017?

NCT03267017 is sponsored by Rambam Health Care Campus.

What drugs are being tested in NCT03267017?

Interventions in NCT03267017: posture changes.

What condition does NCT03267017 study?

NCT03267017 studies Heart Rate Determination.

Is NCT03267017 still recruiting?

NCT03267017 is currently status unknown. Last updated 30 August 2017.

Last reviewed 2017-08-30 · How we verify

NCT03267017

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Correlation Between Respiratory Variability of R-R Intervals and Systolic Pressure Variability

Status unknown Last updated 30 August 2017

What this trial tests

trial testing posture changes in Heart Rate Determination in 40 participants. Status unknown.

Timeline

1 November 2017

Primary endpoint
1 November 2018

1 May 2019

Quick facts

Lead sponsor	Rambam Health Care Campus
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	40
Start date	1 November 2017
Primary completion	1 November 2018
Estimated completion	1 May 2019

Drugs / interventions tested

posture changes

Conditions studied

Heart Rate Determination — all drugs for Heart Rate Determination →

Sponsor

Rambam Health Care Campus — full company profile →

Who can join

Adults 18 to 80, any sex, with Heart Rate Determination. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective study is designed to assess and quantify the correlation between respiratory changes in R-R interval and the respiratory changed in invasive systolic blood pressure in ventilated patients during changes in posture and peak end expiratory pressure (PEEP) and following a fluid bolus

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Heart Rate Determination

Currently open trials in the same condition.

NCT06322264 — Promoting Children's Participation in Conventional X-ray Examinations · recruiting
NCT07404956 — THE EFFECT OF SURGICAL MASK AND N95 MASK USE ON SURGICAL SMOKE IN OPERATING ROOM NURSES · NA · recruiting

Other Rambam Health Care Campus trials

Trials by the same sponsor.

NCT07384013 — Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs · NA · recruiting
NCT06688253 — Intravenous Human IgG1 Fc Fragment (Efgartigimod) in Myasthenic Crisis · Phase 4 · not yet recruiting
NCT06235749 — Administration Of Calcium Gluconate for The Reduction of Blood Loss During Elective Cesarean Delivery · NA · recruiting
NCT06622902 — Influence of Flow Rate Change on CO2 Levels During High Flow Nasal Ventilation (HFNV) in Preterm Infants. · NA · recruiting
NCT05922111 — Cervical Ripening Balloon for 12 Hours vs. 1 Hour. · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03267017 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rambam Health Care Campus
Last refreshed: 30 August 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03267017.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing